ArticleFrontiers in immunology2026
Case Report: Differential diagnosis and clinical management of isolated prolonged activated partial thromboplastin time.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An unexpected, isolated prolongation of activated partial thromboplastin time (APTT) frequently poses diagnostic challenges in coagulation laboratories. This article presents two patients exhibiting isolated prolonged APTT, one with significant bleeding manifestations and another without bleeding symptoms. The first patient was diagnosed with acquired hemophilia A (AHA), whereas antiphospholipid antibodies (aPLs) were suspected to be responsible for the isolated prolonged APTT in the second patient. Accurate identification of the underlying cause of isolated prolonged APTT is crucial for proper diagnosis and subsequent therapeutic management. Furthermore, we summarize potential causes of isolated prolonged APTT and propose a simplified diagnostic algorithm to distinguish between lupus anticoagulants (LA) (more common) and coagulation factor deficiencies (less common). This report aims to provide insights into the clinical management of similar cases in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.